Serveur d'exploration SRAS - Curation (Ncbi)

Index « Mesh.i » - entrée « Inhibitory Concentration 50 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Infusions, Parenteral < Inhibitory Concentration 50 < Injections  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 47.
[0-20] [0 - 20][0 - 47][20-40]
Ident.Authors (with country if any)Title
000012 (2001) C E Stephens [États-Unis] ; T M Felder ; J W Sowell ; G. Andrei ; J. Balzarini ; R. Snoeck ; E. De ClercqSynthesis and antiviral/antitumor evaluation of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes and related compounds as a new class of diarylsulfones.
000013 (2001) D J Hwang [Corée du Sud] ; S N Kim ; J H Choi ; Y S LeeDicaffeoyl- or digalloyl pyrrolidine and furan derivatives as HIV integrase inhibitors.
000360 (2003) Christopher Mcguigan [Royaume-Uni] ; Alison Jukes ; Sally Blewett ; Hubert Barucki ; Jonathan T. Erichsen ; Graciella Andrei ; Robert Snoeck ; Erik De Clercq ; Jan BalzariniHalophenyl furanopyrimidines as potent and selective anti-VZV agents.
000500 (2004) Swee Kee Wong [États-Unis] ; Wenhui Li ; Michael J. Moore ; Hyeryun Choe ; Michael FarzanA 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2.
000A52 (2004) Els Keyaerts ; Leen Vijgen ; Piet Maes ; Johan Neyts ; Marc Van RanstIn vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
001077 (2005) Yu-San Han [République populaire de Chine] ; Gu-Gang Chang ; Chiun-Gung Juo ; Hong-Jen Lee ; Shiou-Hwei Yeh ; John Tsu-An Hsu ; Xin ChenPapain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition.
001412 (2006) Kap-Sun Yeung [États-Unis] ; Gregory A. Yamanaka ; Nicholas A. MeanwellSevere acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention.
001563 (2006) Hui Li [États-Unis] ; John Tatlock ; Angelica Linton ; Javier Gonzalez ; Allen Borchardt ; Peter Dragovich ; Tanya Jewell ; Tom Prins ; Ru Zhou ; Julie Blazel ; Hans Parge ; Robert Love ; Michael Hickey ; Chau Doan ; Stephanie Shi ; Rohit Duggal ; Cristina Lewis ; Shella FuhrmanIdentification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors.
001826 (2007) William E. Severson [États-Unis] ; Nice Shindo ; Mindy Sosa ; Thomas Fletcher ; E Lucile White ; Subramaniam Ananthan ; Colleen B. JonssonDevelopment and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library.
001891 (2007) Masahiro Ikejiri [Japon] ; Masayuki Saijo ; Shigeru Morikawa ; Shuetsu Fukushi ; Tetsuya Mizutani ; Ichiro Kurane ; Tokumi MaruyamaSynthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents.
001A85 (2008) Chunying Niu [Canada] ; Jiang Yin ; Jianmin Zhang ; John C. Vederas ; Michael N G. JamesMolecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro.
001C06 (2008) Monica R. Loizzo [Italie] ; Antoine M. Saab ; Rosa Tundis ; Giancarlo A. Statti ; Francesco Menichini ; Ilaria Lampronti ; Roberto Gambari ; Jindrich Cinatl ; Hans Wilhelm DoerrPhytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species.
001D48 (2008) Arun K. Ghosh [États-Unis] ; Gangli Gong [États-Unis] ; Valerie Grum-Tokars [États-Unis] ; Debbie C. Mulhearn [États-Unis] ; Susan C. Baker [États-Unis] ; Melissa Coughlin [États-Unis] ; Bellur S. Prabhakar [États-Unis] ; Katrina Sleeman [États-Unis] ; Michael E. Johnson [États-Unis] ; Andrew D. Mesecar [États-Unis]Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors
001D73 (2009) Andrea Spallarossa [Italie] ; Sara Cesarini ; Angelo Ranise ; Olga Bruno ; Silvia Schenone ; Paolo La Colla ; Gabriella Collu ; Giuseppina Sanna ; Barbara Secci ; Roberta LoddoNovel modifications in the series of O-(2-phthalimidoethyl)-N-substituted thiocarbamates and their ring-opened congeners as non-nucleoside HIV-1 reverse transcriptase inhibitors.
001D92 (2008) Ka To Shum [Hong Kong] ; Julian A. TannerDifferential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase.
001E54 (2009) Chaewoon Lee [Corée du Sud] ; Jin Moo Lee ; Na-Ra Lee ; Bong-Suk Jin ; Kyoung Jin Jang ; Dong-Eun Kim ; Yong-Joo Jeong ; Youhoon ChongAryl diketoacids (ADK) selectively inhibit duplex DNA-unwinding activity of SARS coronavirus NTPase/helicase.
001F79 (2009) M. Jalali-Heravi [Iran] ; M. Asadollahi-Baboli ; A. Mani-VarnosfaderaniShuffling multivariate adaptive regression splines and adaptive neuro-fuzzy inference system as tools for QSAR study of SARS inhibitors.
001F97 (2009) Melissa M. Coughlin [États-Unis] ; John Babcook ; Bellur S. PrabhakarHuman monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms.
002018 (2009) Ying Guo [États-Unis] ; Jennifer Tisoncik ; Susanna Mcreynolds ; Michael Farzan ; Bellur S. Prabhakar ; Thomas Gallagher ; Lijun Rong ; Michael CaffreyIdentification of a new region of SARS-CoV S protein critical for viral entry.
002064 (2009) Weisheng Luo [République populaire de Chine] ; Xiaojian Su ; Shouji Gong ; Yongjun Qin ; Weibing Liu ; Jia Li ; Haiping Yu ; Qing XuAnti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts.
002144 (2010) R. Ramajayam [Taïwan] ; Kian-Pin Tan ; Hun-Ge Liu ; Po-Huang LiangSynthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Inhibitory Concentration 50" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Inhibitory Concentration 50" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Inhibitory Concentration 50
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021